Issue 3/2019
Content (16 Articles)
Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
U. Anido-Herranz, N. Fernández-Núñez, J. Afonso-Afonso, L. Santomé-Couto, A. Medina-Colmenero, O. Fernández-Calvo, M. Lázaro-Quintela, S. Vázquez
Classical Protein Kinase C: a novel kinase target in breast cancer
R. K. Singh, S. Kumar, M. S. Tomar, P. K. Verma, S. P. Singh, P. K. Gautam, A. Acharya
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
B. Farhood, N. H. Goradel, K. Mortezaee, N. Khanlarkhani, E. Salehi, M. S. Nashtaei, H. Mirtavoos-mahyari, E. Motevaseli, D. Shabeeb, A. E. Musa, M. Najafi
Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder
E. El Rassy, T. Assi, Z. Bakouny, N. Pavlidis, J. Kattan
Baseline 18F-Fluorocholine PET/CT and bone scan in the outcome prediction of patients treated with radium 223 dichloride
A. M. García Vicente, B. González García, M. Amo-Salas, I. García Carbonero, J. Cassinello Espinosa, J. L. Gómez-Aldaraví Gutierrez, L. Suarez Hinojosa, Á. Soriano Castrejón
Prognostic implication of EGFR mutation status and subtype in resected lung adenocarcinoma patients irrespective of therapy
R. Li, Q. Li, S. Lin, W. Li, L. Yu, L. Wang, X. Dong, L. Yu, S. Li, W. Liu, B. Li
The Medical Oncology resident mentor: situation and workload
E. Elez, T. Quintanar, J. Bosch-Barrera, J. Corral, N. Lainez, V. Moreno, C. A. Rodriguez, E. Gonzalez-Flores, A. Cervantes
Effectiveness, safety and cost of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world data analysis
M. Koninckx, J. L. Marco, I. Pérez, M. T. Faus, V. Alcolea, F. Gómez
Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers
A. Sabaté-Llobera, L. Gràcia-Sánchez, G. Reynés-Llompart, E. Ramos, L. Lladó, J. Robles, T. Serrano, J. Mestres-Martí, C. Gámez-Cenzano
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage infiltration
P. Chen, J. Zhou, J. Li, Q. Zhang, Q. Zuo
Measurement of circulating tumor cells in squamous cell carcinoma of the head and neck and patient outcomes
T. M. Morgan, X. Wang, X. Qian, J. M. Switchenko, S. Nie, K. R. Patel, R. J. Cassidy, D. M. Shin, J. J. Beitler
Lung cancer patients with a previous extra-pulmonary malignancy should not be considered homogeneous: a clinicopathological analysis of 3530 surgical cases
X.-L. Hu, S.-T. Xu, X.-C. Wang, D.-N. Hou, C. Bao, D. Yang, Y.-L. Song
Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival
F. Casas, I. Valduvieco, G. Oses, L. Izquierdo, I. Archila, M. Costa, K. S. Cortes, T. Barreto, F. Ferrer
Evaluation of safety and efficacy of p53MVA vaccine combined with pembrolizumab in patients with advanced solid cancers
V. Chung, F. J. Kos, N. Hardwick, Y. Yuan, J. Chao, D. Li, J. Waisman, M. Li, K. Zurcher, P. Frankel, D. J. Diamond
Retroperitoneal fibrosis secondary to non-urology carcinomas: a clinical and outcome analysis of 97 cases
T. Chen, L. Tian, D. Fan, F. Wu, J. Lu, S. Ding
Active study: undetected prevalence and clinical inertia in the treatment of breakthrough cancer pain (BTcP)
C. Camps Herrero, J. J. Reina Zoilo, D. Monge Martín, F. Caballero Martínez, V. Guillem Porta, E. Aranda Aguilar, A. Carrato Mena, E. Díaz-Rubio García, J. García-Foncillas López, M. Feijóo Saus, R. López López